Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds : vimarsana.com

SEC has recommended restricted emergency use of Biological E's COVID-19 vaccine, Corbevax, in children aged 5-12 years

Related Keywords

India , New Delhi , Delhi , Bharat , , Expert Committee , Subject Expert Committee , Drug Controller General , Bharat Biotech , Covaxin For Children , Ovid Vaccination For Children , Ovaxin Data , Estricted Emergency Of Covaxin , Ndia Vaccination For Children , 12 Years Vaccination ,